{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:10:51Z","timestamp":1768878651388,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013203","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000}}],"reference-count":163,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013203.pub2","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:11:16Z","timestamp":1579900276000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis"],"prefix":"10.1002","author":[{"given":"Lawrence MJ","family":"Best","sequence":"first","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; Rowland Hill Street London UK NW32PF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Leung","sequence":"additional","affiliation":[{"name":"University College London; Medical School; Gower Street London UK WC1H6BT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne C","family":"Freeman","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J","family":"Sutton","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola J","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Jane","family":"Milne","sequence":"additional","affiliation":[{"name":"Coventry University; Centre for Trust, Peace and Social Relations; Coventry UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine","family":"Cowlin","sequence":"additional","affiliation":[{"name":"PSC Support; PO Box 6945 London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Payne","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust; HPB and Liver Transplant Surgery; Pond Street London Greater London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Walshaw","sequence":"additional","affiliation":[{"name":"Barts and The London NHS Trust; Acute Medicine; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chavdar S","family":"Pavlov","sequence":"additional","affiliation":[{"name":"'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\\1 Moscow Russian Federation 119881"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R","family":"Davidson","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; Rowland Hill Street London UK NW32PF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman R","family":"Williams","sequence":"additional","affiliation":[{"name":"UCL Division of Surgery & Interventional Science; Surgical & Interventional Trials Unit (SITU); 3rd Floor, Charles Bell House 43 - 45 Foley Street London UK W1W 7TY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"University College London; Division of Surgery and Interventional Science; Rowland Hill Street London UK NW32PF"},{"name":"'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\\1 Moscow Russian Federation 119881"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"10.1002\/14651858.CD013203.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0041-1345(00)02507-0","article-title":"Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial","volume":"33","author":"Belli","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD013203.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/j.1600-6143.2010.03164.x","article-title":"ATG-fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation","volume":"10","author":"Benitez","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD013203.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.transproceed.2004.12.064","article-title":"Hepatic ischemia\/reperfusion injury can be modulated with thymoglobulin induction therapy","volume":"37","author":"Bogetti","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0012.2005.00375.x","article-title":"Thymoglobulin induction protects liver allografts from ischemia\/reperfusion injury","volume":"19","author":"Bogetti","year":"2005","journal-title":"Clinical Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD013203.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/lt.20307","article-title":"Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study","volume":"11","author":"Boillot","year":"2005","journal-title":"Liver Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/lt.21905","article-title":"Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study","volume":"15","author":"Boillot","year":"2009","journal-title":"Liver Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/TP.0b013e3181db8cf0","article-title":"Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients","volume":"89","author":"Calmus","year":"2010","journal-title":"Transplantation"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0008|cit8","first-page":"482a","article-title":"Evaluation of the benefit on renal function of a delayed introduction of tacrolimus in liver transplant recipients at 13 French centers","volume":"46","author":"Calmus","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jlts.2001.26353","article-title":"Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial","volume":"7","author":"Eason","year":"2001","journal-title":"Liver Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.TP.0000062834.30922.FE","article-title":"Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy","volume":"75","author":"Eason","year":"2003","journal-title":"Transplantation"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0011|cit11","first-page":"241a","article-title":"Severity of recurrent hepatitis C infection after liver transplant: a comparative study between steroid induction vs induction with rabbit anti thymocyte globulin: results of a randomized controlled study","volume":"40","author":"Nair","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.tp.0000181192.13836.8c","article-title":"Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection","volume":"81","author":"Nair","year":"2006","journal-title":"Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD013203.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/01.TP.0000140881.07208.4E","article-title":"Double-blind comparison of hepatitis C histological recurrence rate in HCV+ liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine","volume":"78","author":"Filipponi","year":"2004","journal-title":"Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1007\/s10620-014-3215-2","article-title":"Impact of anti-thymocyte globulin during immunosuppression induction in patients with hepatitis C after liver transplantation","volume":"59","author":"Garcia-Saenz-de-Sicilia","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0015|cit15","first-page":"539","article-title":"A randomized, single-center trial comparing thymoglobulin (TG) induction therapy and delayed initiation of tacrolimus to no induction with immediate initiation of tacrolimus in liver transplant (LT) recipients to assess the impact on renal function","volume":"3","author":"Grant","year":"2012","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0016|cit16","first-page":"100","article-title":"A randomized, single-center trial comparing thymoglobulin induction therapy and delayed initiation of tacrolimus to no induction with immediate initiation of tacrolimus in liver transplant recipients to assess the impact on renal function - interim analysis","volume":"4","author":"Grant","year":"2010","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0017|cit17","unstructured":"NCT00564538 A study of thymoglobulin and tacrolimus in liver transplant clinicaltrials.gov\/ct2\/show\/NCT00564538"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0018|cit18","first-page":"S100","article-title":"A randomized, single-center trial comparing thymoglobulin (TG) induction therapy and delayed initiation of tacrolimus (TCR) to no induction with immediate initiation of TCR in liver transplant recipients to assess the impact on hepatitis C. recurrence","volume":"18","author":"Sicilia","year":"2012","journal-title":"Liver Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013203.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.hpb.2018.06.056","article-title":"Randomised study on steroid free immunosuppression with basiliximab induction vs standard triple drug immunosuppression in adult live donor liver transplantation (LDLT). CTRI\/2017\/08\/009508","volume":"20","author":"Kathirvel","year":"2018","journal-title":"HPB: the Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0020|cit20","first-page":"32","article-title":"Randomised study of steroid free immunosuppression with basiliximab induction vs standard triple drug immunosuppression in adult live donor liver transplantation (LDLT). Ctri\/2017\/08\/009508","volume":"102","author":"Kathirvel","year":"2018","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD013203.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.tp.0000282914.20578.7b","article-title":"Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year","volume":"84","author":"Kato","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.transproceed.2004.12.042","article-title":"Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study","volume":"37","author":"Kato","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0023|cit23","first-page":"163a","article-title":"Multicenter randomized hepatitis C (HCV) three trial post liver transplantation (OLT): a 90-day report","volume":"40","author":"Fasola","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/lt.22417","article-title":"A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C","volume":"17","author":"Klintmalm","year":"2011","journal-title":"Liver Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0025|cit25","first-page":"S105","article-title":"Hepatitis C (HCV)-3 study: benefits of a steroid-free immunosuppression (IS) regimen in HCV-infected liver transplant recipients (OLT) may become evident only after long-term follow up","volume":"14","author":"Klintmalm","year":"2008","journal-title":"Liver Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/lt.21182","article-title":"Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study","volume":"13","author":"Klintmalm","year":"2007","journal-title":"Liver Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study","volume":"14","author":"Klintmalm","year":"2014","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2005.12.010","article-title":"Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study","volume":"44","author":"Llado","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/lt.21629","article-title":"Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study","volume":"14","author":"Llad\u00f3","year":"2008","journal-title":"Liver Transplantation"},{"issue":"48","key":"10.1002\/14651858.CD013203.pub2-BIB0030|cit30","first-page":"3389","article-title":"Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens","volume":"86","author":"Lu","year":"2006","journal-title":"Chung-Hua I Hsueh Tsa Chih"},{"issue":"7","key":"10.1002\/14651858.CD013203.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/TP.0b013e318186b8a3","article-title":"Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial","volume":"86","author":"Lupo","year":"2008","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD013203.pub2-BIB0032|cit32","first-page":"C75","article-title":"Basiliximab vs steroids in liver transplantation immunosuppression. A prospective randomized clinical trial","volume":"11","author":"Lupo","year":"2005","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0033|cit33","unstructured":"NCT00343226 An open, randomized pilot study to evaluate the use of basiliximab with an optimized cyclosporine dosing on renal function in de novo liver transplantation clinicaltrials.gov\/ct2\/show\/NCT00343226"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/jlts.2002.30302","article-title":"Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial","volume":"8","author":"Neuhaus","year":"2002","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"894215","DOI":"10.1155\/2012\/894215","article-title":"A randomized multicenter study comparing a tacrolimus-based protocol with and without steroids in HCV-positive liver allograft recipients","volume":"2012","author":"Neumann","year":"2012","journal-title":"Journal of Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0036|cit36","unstructured":"NCT00296244 Steroid free immunosuppression in liver transplantation clinicaltrials.gov\/ct2\/show\/NCT00296244"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ctr.12119","article-title":"Completely steroid-free immunosuppression in liver transplantation: a randomized study","volume":"27","author":"Ramirez","year":"2013","journal-title":"Clinical Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0038|cit38","first-page":"S109","article-title":"Enteric coated mycophenolate sodium with basiliximab induction, tacrolimus with or without steroids is safe and effective in adult liver transplantation","volume":"14","author":"Ramirez","year":"2008","journal-title":"Liver Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0039|cit39","first-page":"S109","article-title":"Safety and efficacy of steroid-free immunosuppression using basiliximab induction, tacrolimus and enteric coated mycophenolate sodium in adult liver transplantation","volume":"14","author":"Ramirez","year":"2008","journal-title":"Liver Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0040|cit40","first-page":"15","article-title":"Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial","volume":"12","author":"Schmeding","year":"2007","journal-title":"Annals of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD013203.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/00007890-199905270-00003","article-title":"A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation","volume":"67","author":"Tisone","year":"1999","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1111\/j.1432-2277.1998.tb01130.x","article-title":"Immunosuppression without prednisone after liver transplantation is safe and associated with normal early graft function: preliminary results of a randomized study","volume":"11","author":"Tisone","year":"1998","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0041-1345(98)00310-8","article-title":"Metabolic findings after liver transplantation within a randomised trial with or without steroids","volume":"30","author":"Tisone","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD013203.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00007890-200111270-00018","article-title":"Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil","volume":"72","author":"Washburn","year":"2001","journal-title":"Transplantation"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0045|cit45","first-page":"S105","article-title":"Safety of thymoglobulin in minimizing maintenance immunosuppression in liver transplant recipients with renal dysfunction","volume":"14","author":"Washburn","year":"2008","journal-title":"Liver Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","article-title":"Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0047|cit47","unstructured":"EUCTR2009-010640-34-IT Induction of donor-specific tolerance in patients with liver transplantation with recipient pre-treatment with thymoglobuline and minimal post-transplant immunosuppression apps.who.int\/trialsearch\/trial2.aspx?Trialid=euctr2009-010640-34-it"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00007890-199410270-00006","article-title":"A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of an European and Australian multicenter study","volume":"58","author":"Farges","year":"1994","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0041-1345(98)00572-7","article-title":"Anti-il-2 receptor bt563 versus placebo: a randomized trial for induction therapy after liver transplantation","volume":"30","author":"Glanemann","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/SLA.0000000000002943","article-title":"Tacrolimus and single intraoperative high-dose of anti-T lymphocyte globulins versus tacrolimus monotherapy in adult liver transplantation one-year results of an investigator-driven randomized controlled trial","volume":"268","author":"Iesari","year":"2018","journal-title":"Annals of Surgery"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1097\/01.tp.0000543147.59147.7b","article-title":"Tacrolimus (Tac) and single intra-operative high-dose of R-ATG induction vs. tacrolimus monotherapy as immunosuppression (IS) in adult liver transplantation (LT): one-year results of an investigator-driven, prospective, randomized, controlled trial (RCT)","volume":"102","author":"Iesari","year":"2018","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00007890-199505150-00013","article-title":"Enisoprost in liver transplantation","volume":"59","author":"Ismail","year":"1995","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0053|cit53","unstructured":"EUCTR2007-004822-26-GB A randomised pilot trial of a steroid-free immunosuppressant regimen in paediatric liver transplantation - a pilot trial of paediatric liver transplantation without steroids apps.who.int\/trialsearch\/trial2.aspx?Trialid=euctr2007-004822-26-gb"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0054|cit54","unstructured":"ISRCTN49665078 A randomised pilot trial of a steroid-free immunosuppressant regimen in paediatric liver transplantation www.isrctn.com\/ISRCTN496"},{"issue":"1","key":"10.1002\/14651858.CD013203.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/jlts.2002.29763","article-title":"A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C","volume":"8","author":"Jain","year":"2002","journal-title":"Liver Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0041-1345(98)00308-X","article-title":"Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation","volume":"30","author":"Klupp","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/S0041-1345(01)02011-5","article-title":"Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial","volume":"33","author":"Langrehr","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0041-1345(00)02579-3","article-title":"A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation","volume":"33","author":"Langrehr","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0059|cit59","first-page":"303-12","article-title":"A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation","volume":"12","author":"Langrehr","year":"1998","journal-title":"Clinical Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0041-1345(98)00309-1","article-title":"A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT","volume":"30","author":"Langrehr","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0061|cit61","first-page":"3204","article-title":"Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study","volume":"28","author":"Langrehr","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00007890-199706270-00012","article-title":"A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation","volume":"63","author":"Langrehr","year":"1997","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0b013e31819009c9","article-title":"Tacrolimus monotherapy in liver transplantation one-year results of a prospective, randomized, double-blind, placebo-controlled study","volume":"248","author":"Lerut","year":"2008","journal-title":"Annals of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/SLA.0000000000000969","article-title":"Is minimal, steroid-free immunosuppression a safe approach in adult liver transplantation?: long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study","volume":"260","author":"Lerut","year":"2014","journal-title":"Annals of Surgery"},{"issue":"31","key":"10.1002\/14651858.CD013203.pub2-BIB0065|cit65","first-page":"5601","article-title":"Application of daclizumab as an immune induction therapy after liver transplantation","volume":"17","author":"Liu","year":"2013","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1432-2277.2005.00217.x","article-title":"A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C","volume":"18","author":"Margarit","year":"2005","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0067|cit67","unstructured":"NCT00117689 Evaluation of thymoglobulin induction and reduced doses of calcineurin inhibitors on liver transplant rejection clinicaltrials.gov\/ct2\/show\/NCT00117689"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0068|cit68","unstructured":"NCT00321074 Tacrolimus and daclizumab versus tacrolimus and steroids in liver recipients receiving sub-optimal grafts clinicaltrials.gov\/ct2\/show\/NCT00321074"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0069|cit69","unstructured":"NCT00538265 Benefit of immunoprophylaxis on fibrosis to reduce viral load after liver transplantation clinicaltrials.gov\/ct2\/show\/NCT00538265"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0070|cit70","unstructured":"NCT03315052 Budesonide for immunosuppression after liver transplantation to reduce side effects clinicaltrials.gov\/ct2\/show\/NCT03315052"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'respect' study","volume":"9","author":"Neuberger","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1477-2574.2012.00576.x","article-title":"A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years","volume":"15","author":"Pelletier","year":"2013","journal-title":"HPB: the Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.transproceed.2004.12.153","article-title":"Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation","volume":"37","author":"Pelletier","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00007890-199303000-00015","article-title":"Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing okt3 and anti-il-2 receptor monoclonal antibody lo-tact-1","volume":"55","author":"Reding","year":"1993","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.jamcollsurg.2016.08.480","article-title":"A randomized, prospective, pilot study of tacrolimus-sparing immunosuppression induction with basiliximab, in patients undergoing orthotopic liver transplantation with pre-orthotopic liver transplantation renal dysfunction","volume":"223","author":"Russell","year":"2016","journal-title":"Journal of the American College of Surgeons"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/TP.0000000000001228","article-title":"Corticosteroid-sparing and optimization of mycophenolic acid exposure in liver transplant recipients receiving mycophenolate mofetil and tacrolimus: a randomized, multicenter study","volume":"100","author":"Saliba","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0041-1345(98)00286-3","article-title":"Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation","volume":"30","author":"Samuel","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0041-1345(02)03006-3","article-title":"Tacrolimus is effective in both dual and triple regimens after liver transplantation","volume":"34","author":"Serrano","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Suppl","key":"10.1002\/14651858.CD013203.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00007890-201407151-00486","article-title":"Renal function outcomes with tacrolimus qd after de novo liver transplantation for different primary diseases: ad hoc analysis from the diamond randomized, controlled trial","volume":"98","author":"Bechstein","year":"2014","journal-title":"Transplantation"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0080|cit80","first-page":"S211","article-title":"Renal function outcomes with tacrolimus qd after de novo liver transplantation for different primary diseases: ad hoc analysis from the diamond randomized, controlled trial","volume":"100","author":"Bechstein","year":"2016","journal-title":"Transplantation"},{"issue":"Suppl","key":"10.1002\/14651858.CD013203.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00007890-201407151-02415","article-title":"Renal function outcomes with tacrolimus qd after de novo liver transplantation for different baseline EGFR: ad hoc analysis from the diamond randomized controlled trial","volume":"98","author":"Tisone","year":"2014","journal-title":"Transplantation"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0082|cit82","first-page":"S126","article-title":"Renal function outcomes with tacrolimus qd after de novo liver transplantation for different baseline EGFR: ad hoc analysis from the diamond randomized controlled trial","volume":"100","author":"Tisone","year":"2016","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013203.pub2-BIB0083|cit83","first-page":"79","article-title":"Long-term prolonged-release tacrolimus based immunosuppression in de novo liver transplant patients: 3-year prospective follow-up of the diamond study","volume":"30","author":"Trunecka","year":"2017","journal-title":"Transplant International"},{"issue":"7","key":"10.1002\/14651858.CD013203.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.13182","article-title":"Renal function in de novo liver transplant recipients receiving different prolonged-release tacrolimus regimens-the diamond study","volume":"15","author":"Trunecka","year":"2015","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0085|cit85","first-page":"55","article-title":"Renal function outcomes with prolonged release tacrolimus according to donor age after de novo liver transplantation: a post hoc analysis from the diamond randomized, controlled trial","volume":"28","author":"Trunecka","year":"2015","journal-title":"Transplant International"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0086|cit86","first-page":"S255","article-title":"Renal function outcomes with prolonged-release tacrolimus according to donor age after de novo liver transplantation: a post hoc analysis from the diamond randomized, controlled trial","volume":"100","author":"Trunecka","year":"2016","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2044.2006.04532.x","article-title":"Effect of perioperative steroids on renal function after liver transplantation","volume":"61","author":"Turner","year":"2006","journal-title":"Anaesthesia"},{"issue":"8","key":"10.1002\/14651858.CD013203.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.TP.0000116562.15920.43","article-title":"Preliminary experience with alemtuzumab (campath-1h) and low-dose tacrolimus immunosuppression in adult liver transplantation","volume":"77","author":"Tzakis","year":"2004","journal-title":"Transplantation"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD013203.pub2-BIB0089|cit89","first-page":"87","article-title":"Tacrolimus as the only immunosuppressant in liver transplantation. Comparison with a doublet regimen with tacrolimus and corticosteroids","volume":"24","author":"Bilbao","year":"2001","journal-title":"Gastroenterologia y Hepatologia"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0090|cit90","first-page":"8","article-title":"Steroid-free immunosuppression with tacrolimus following induction with daclizumab in liver transplant patients: results of a randomized clinical trial","volume":"28","author":"Bilbao","year":"2005","journal-title":"Gastroenterologia y Hepatologia"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0091|cit91","unstructured":"NCT02123108 Safety and efficacy of basiliximab, delayed dose tacrolimus plus ECMPA following liver transplantation clinicaltrials.gov\/ct2\/show\/NCT02123108"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0092|cit92","unstructured":"NCT02544113 A randomized controlled clinical trial of thymoglobulin\u00ae after liver transplantation clinicaltrials.gov\/ct2\/show\/NCT02544113"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/TP.0b013e318225db4d","article-title":"Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score","volume":"92","author":"Barber","year":"2011","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013103","article-title":"Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis","author":"Best","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0095|cit95","unstructured":"British National Formulary Drugs www.medicinescomplete.com\/#\/browse\/bnf"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0096|cit96","unstructured":"Centers for Disease Control and Prevention Chronic liver disease and cirrhosis, 2018 www.cdc.gov\/nchs\/fastats\/liver-disease.htm"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD013203.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013203.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/00365521.2012.661759","article-title":"Incidence, etiology and mortality of cirrhosis: a population-based cohort study","volume":"47","author":"Dam Fialla","year":"2012","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0102|cit102","unstructured":"Davies S Chief Medical Officer annual report 2011: volume 1 www.gov.uk\/government\/publications\/cmo-annual-report-2011-volume-one-on-the-state-of-the-public-s-health"},{"issue":"7-8","key":"10.1002\/14651858.CD013203.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0104|cit104","unstructured":"Dias S Sutton AJ Welton NJ Ades AE NICE DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment, September 2011 (last updated April 2012) nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD3-Heterogeneity.final-report.08.05.12.pdf"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0105|cit105","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU technical support document 1: introduction to evidence synthesis for decision making, April 2011 (last updated April 2012) scharr.dept.shef.ac.uk\/nicedsu\/wp-content\/uploads\/sites\/7\/2016\/03\/TSD1-Introduction.final_.08.05.12.pdf"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0106|cit106","unstructured":"Dias S Welton NJ Sutton AJ Caldwell DM Lu G Ades AE NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials, May 2011 (last updated April 2014) nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD4-Inconsistency.final_.15April2014.pdf"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0107|cit107","unstructured":"Dias S Welton NJ Sutton AJ Ades AE NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, August 2011 (last updated September 2016) www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0088912\/pdf\/PubMedHealth_PMH0088912.pdf"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0108|cit108","first-page":"38","article-title":"Daclizumab withdrawn from the market worldwide","volume":"56","author":"DTB","year":"2018","journal-title":"Drug and Therapeutics Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/SLA.0b013e3181f5f23a","article-title":"Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors","volume":"252","author":"Duffy","year":"2010","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0110|cit110","unstructured":"European Liver Transplant Registry Evolution of LTs in Europe www.eltr.org\/spip.php?article152"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0111|cit111","unstructured":"EuroQol EQ-5D Instruments | About EQ-5D, 2018 euroqol.org\/eq-5d-instruments\/"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007606.pub4","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients","author":"Fairfield","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0113|cit113","unstructured":"US Food Drug Administration Vaccines, Blood & Biologics. Thymoglobulin www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/UCM117134.pdf"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.2008.163527","article-title":"Immunosuppression for liver transplantation","volume":"58","author":"Geissler","year":"2009","journal-title":"Gut"},{"issue":"19-20","key":"10.1002\/14651858.CD013203.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00508-016-1046-1","article-title":"Indications for liver transplantation in adults: recommendations of the Austrian Society for Gastroenterology and Hepatology (OGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)","volume":"128","author":"Graziadei","year":"2016","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"e025045","DOI":"10.1136\/bmjopen-2018-025045","article-title":"Top research priorities in liver and gallbladder disorders in the UK","volume":"9","author":"Gurusamy","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005161.pub2","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","author":"Haddad","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0119|cit119","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0122|cit122","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"21","key":"10.1002\/14651858.CD013203.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/sim.6188","article-title":"A design-by-treatment interaction model for network meta-analysis with random inconsistency effects","volume":"33","author":"Jackson","year":"2014","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013203.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ajt.14559","article-title":"OPTN\/SRTR 2016 annual data report: liver","volume":"18","author":"Kim","year":"2018","journal-title":"American Journal of Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"27","key":"10.1002\/14651858.CD013203.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3748\/wjg.v16.i27.3457","article-title":"Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis","volume":"16","author":"Lan","year":"2010","journal-title":"World Journal of Gastroenterology"},{"issue":"9859","key":"10.1002\/14651858.CD013203.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"474","key":"10.1002\/14651858.CD013203.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"12","key":"10.1002\/14651858.CD013203.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"issue":"9128","key":"10.1002\/14651858.CD013203.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"9871","key":"10.1002\/14651858.CD013203.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(13)60355-4","article-title":"UK health performance: findings of the Global Burden of Disease Study 2010","volume":"381","author":"Murray","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0133|cit133","unstructured":"NCBI Graft rejection www.ncbi.nlm.nih.gov\/mesh\/68006084"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/21.5.837","article-title":"Intention-to-treat analysis: implications for quantitative and qualitative research","volume":"21","author":"Newell","year":"1992","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0135|cit135","unstructured":"NHS Blood and Transplant Annual report on liver transplantation. Report for 2017\/2018 (1 April 2008 to 31 March 2018) www.nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/12250\/nhsbt-liver-transplantation-annual-report-2017-2018.pdf"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0136|cit136","unstructured":"Members of OpenBUGS Project Management Group OpenBUGS 2014"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0137|cit137","unstructured":"Optum Patient-reported Outcomes | What We Do | SF Health Surveys | SF-36v2 Health Survey, 2018 campaign.optum.com\/optum-outcomes\/what-we-do\/health-surveys\/sf-36v2-health-survey.html"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008852.pub2","article-title":"Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients","author":"Penninga","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010252.pub2","article-title":"Antibody induction versus corticosteroid induction for liver transplant recipients","author":"Penninga","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010253.pub2","article-title":"Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients","author":"Penninga","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0141|cit141","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ajg.2013.405","article-title":"Diagnosis of liver cirrhosis in England, a cohort study, 1998-2009: a comparison with cancer","volume":"109","author":"Ratib","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/bja\/44.9.910","article-title":"Clinical physiology of the liver","volume":"44","author":"Read","year":"1972","journal-title":"British Journal of Anaesthesia"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011639.pub2","article-title":"Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis","author":"Rodriguez-Peralvarez","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"35","key":"10.1002\/14651858.CD013203.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/ajt.12384","article-title":"Twenty-year longitudinal follow-up after orthotopic liver transplantation: a single-center experience of 313 consecutive cases","volume":"13","author":"Schoening","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD013203.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD013203.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0155|cit155","unstructured":"StataCorp Stata 2017"},{"issue":"3","key":"10.1002\/14651858.CD013203.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"Valkenhoef","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"4","key":"10.1002\/14651858.CD013203.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/lt.23836","article-title":"Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis","volume":"20","author":"Wan","year":"2014","journal-title":"Liver Transplantation"},{"issue":"7644","key":"10.1002\/14651858.CD013203.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1002\/14651858.CD013203.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life","volume":"34","author":"Yang","year":"2014","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD013203.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nunez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD013203.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"524-30.e1; quiz","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD013203.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013203","article-title":"Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis","author":"Gurusamy","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013203.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:15:50Z","timestamp":1628550950000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD013203.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":163,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013203.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]}}}